Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 182

1.

Exercise Engagement as a Moderator of the Effects of APOE Genotype on Amyloid Deposition.

Head D, Bugg JM, Goate AM, Fagan AM, Mintun MA, Benzinger T, Holtzman DM, Morris JC.

Arch Neurol. 2012 May;69(5):636-43.

PMID:
22232206
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Exercise and Alzheimer's disease biomarkers in cognitively normal older adults.

Liang KY, Mintun MA, Fagan AM, Goate AM, Bugg JM, Holtzman DM, Morris JC, Head D.

Ann Neurol. 2010 Sep;68(3):311-8. doi: 10.1002/ana.22096.

PMID:
20818789
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Role of family history for Alzheimer biomarker abnormalities in the adult children study.

Xiong C, Roe CM, Buckles V, Fagan A, Holtzman D, Balota D, Duchek J, Storandt M, Mintun M, Grant E, Snyder AZ, Head D, Benzinger TL, Mettenburg J, Csernansky J, Morris JC.

Arch Neurol. 2011 Oct;68(10):1313-9. doi: 10.1001/archneurol.2011.208.

PMID:
21987546
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Cortical binding of pittsburgh compound B, an endophenotype for genetic studies of Alzheimer's disease.

Hinrichs AL, Mintun MA, Head D, Fagan AM, Holtzman DM, Morris JC, Goate AM.

Biol Psychiatry. 2010 Mar 15;67(6):581-3. doi: 10.1016/j.biopsych.2009.09.012. Epub 2009 Nov 5.

PMID:
19892322
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

APOE modifies the association between Aβ load and cognition in cognitively normal older adults.

Kantarci K, Lowe V, Przybelski SA, Weigand SD, Senjem ML, Ivnik RJ, Preboske GM, Roberts R, Geda YE, Boeve BF, Knopman DS, Petersen RC, Jack CR Jr.

Neurology. 2012 Jan 24;78(4):232-40. doi: 10.1212/WNL.0b013e31824365ab. Epub 2011 Dec 21.

PMID:
22189452
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Association of lifetime cognitive engagement and low β-amyloid deposition.

Landau SM, Marks SM, Mormino EC, Rabinovici GD, Oh H, O'Neil JP, Wilson RS, Jagust WJ.

Arch Neurol. 2012 May;69(5):623-29.

PMID:
22271235
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging.

Morris JC, Roe CM, Xiong C, Fagan AM, Goate AM, Holtzman DM, Mintun MA.

Ann Neurol. 2010 Jan;67(1):122-31. doi: 10.1002/ana.21843.

PMID:
20186853
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

11C-PiB imaging of human immunodeficiency virus-associated neurocognitive disorder.

Ances BM, Benzinger TL, Christensen JJ, Thomas J, Venkat R, Teshome M, Aldea P, Fagan AM, Holtzman DM, Morris JC, Clifford DB.

Arch Neurol. 2012 Jan;69(1):72-7. doi: 10.1001/archneurol.2011.761.

PMID:
22232345
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

APOE4 allele disrupts resting state fMRI connectivity in the absence of amyloid plaques or decreased CSF Aβ42.

Sheline YI, Morris JC, Snyder AZ, Price JL, Yan Z, D'Angelo G, Liu C, Dixit S, Benzinger T, Fagan A, Goate A, Mintun MA.

J Neurosci. 2010 Dec 15;30(50):17035-40. doi: 10.1523/JNEUROSCI.3987-10.2010.

PMID:
21159973
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Pittsburgh compound B-negative dementia: a possibility of misdiagnosis of patients with non-alzheimer disease-type dementia as having AD.

Shimada H, Ataka S, Takeuchi J, Mori H, Wada Y, Watanabe Y, Miki T.

J Geriatr Psychiatry Neurol. 2011 Sep;24(3):123-6. doi: 10.1177/0891988711409410. Epub 2011 Jul 12.

PMID:
21750305
[PubMed - indexed for MEDLINE]
11.

Transforming cerebrospinal fluid Aβ42 measures into calculated Pittsburgh Compound B units of brain Aβ amyloid.

Weigand SD, Vemuri P, Wiste HJ, Senjem ML, Pankratz VS, Aisen PS, Weiner MW, Petersen RC, Shaw LM, Trojanowski JQ, Knopman DS, Jack CR Jr; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2011 Mar;7(2):133-41. doi: 10.1016/j.jalz.2010.08.230. Epub 2011 Feb 1.

PMID:
21282074
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Effects of APOE ε4 on brain amyloid, lacunar infarcts, and white matter lesions: a study among patients with subcortical vascular cognitive impairment.

Kim HJ, Ye BS, Yoon CW, Cho H, Noh Y, Kim GH, Choi YS, Kim JH, Jeon S, Lee JM, Kim JS, Choe YS, Lee KH, Kim ST, Kim C, Kang DR, Ki CS, Lee JH, Werring DJ, Weiner MW, Na DL, Seo SW.

Neurobiol Aging. 2013 Nov;34(11):2482-7. doi: 10.1016/j.neurobiolaging.2013.05.009. Epub 2013 Jun 12.

PMID:
23769398
[PubMed - indexed for MEDLINE]
13.

Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study.

Villain N, Chételat G, Grassiot B, Bourgeat P, Jones G, Ellis KA, Ames D, Martins RN, Eustache F, Salvado O, Masters CL, Rowe CC, Villemagne VL; AIBL Research Group.

Brain. 2012 Jul;135(Pt 7):2126-39. doi: 10.1093/brain/aws125. Epub 2012 May 23.

PMID:
22628162
[PubMed - indexed for MEDLINE]
Free Article
14.

Hypometabolism in Alzheimer-affected brain regions in cognitively healthy Latino individuals carrying the apolipoprotein E epsilon4 allele.

Langbaum JB, Chen K, Caselli RJ, Lee W, Reschke C, Bandy D, Alexander GE, Burns CM, Kaszniak AW, Reeder SA, Corneveaux JJ, Allen AN, Pruzin J, Huentelman MJ, Fleisher AS, Reiman EM.

Arch Neurol. 2010 Apr;67(4):462-8. doi: 10.1001/archneurol.2010.30.

PMID:
20385913
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease.

Morris JC, Roe CM, Grant EA, Head D, Storandt M, Goate AM, Fagan AM, Holtzman DM, Mintun MA.

Arch Neurol. 2009 Dec;66(12):1469-75. doi: 10.1001/archneurol.2009.269.

PMID:
20008650
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Progression of cerebral amyloid load is associated with the apolipoprotein E ε4 genotype in Alzheimer's disease.

Grimmer T, Tholen S, Yousefi BH, Alexopoulos P, Förschler A, Förstl H, Henriksen G, Klunk WE, Mathis CA, Perneczky R, Sorg C, Kurz A, Drzezga A.

Biol Psychiatry. 2010 Nov 15;68(10):879-84. doi: 10.1016/j.biopsych.2010.05.013. Epub 2010 Jul 2.

PMID:
20598287
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Amyloid tracers detect multiple binding sites in Alzheimer's disease brain tissue.

Ni R, Gillberg PG, Bergfors A, Marutle A, Nordberg A.

Brain. 2013 Jul;136(Pt 7):2217-27. doi: 10.1093/brain/awt142. Epub 2013 Jun 11.

PMID:
23757761
[PubMed - indexed for MEDLINE]
Free Article
18.

Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.

Sunderland T, Mirza N, Putnam KT, Linker G, Bhupali D, Durham R, Soares H, Kimmel L, Friedman D, Bergeson J, Csako G, Levy JA, Bartko JJ, Cohen RM.

Biol Psychiatry. 2004 Nov 1;56(9):670-6.

PMID:
15522251
[PubMed - indexed for MEDLINE]
19.

Physical activity and amyloid-β plasma and brain levels: results from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing.

Brown BM, Peiffer JJ, Taddei K, Lui JK, Laws SM, Gupta VB, Taddei T, Ward VK, Rodrigues MA, Burnham S, Rainey-Smith SR, Villemagne VL, Bush A, Ellis KA, Masters CL, Ames D, Macaulay SL, Szoeke C, Rowe CC, Martins RN.

Mol Psychiatry. 2013 Aug;18(8):875-81. doi: 10.1038/mp.2012.107. Epub 2012 Aug 14.

PMID:
22889922
[PubMed - indexed for MEDLINE]
20.

Genetic variants in PSEN2 and correlation to CSF β-amyloid42 levels in AD.

Lebedeva E, Stingl JC, Thal DR, Ghebremedhin E, Strauss J, Özer E, Bertram L, von Einem B, Tumani H, Otto M, Riepe MW, Högel J, Ludolph AC, von Arnim CA.

Neurobiol Aging. 2012 Jan;33(1):201.e9-18. doi: 10.1016/j.neurobiolaging.2010.07.017. Epub 2010 Sep 18.

PMID:
20850903
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk